000 01368 a2200385 4500
005 20250516211607.0
264 0 _c20150115
008 201501s 0 0 eng d
022 _a1791-2423
024 7 _a10.3892/ijo.2014.2398
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcDonald, C
245 0 0 _aPeroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity.
_h[electronic resource]
260 _bInternational journal of oncology
_cJul 2014
300 _a219-26 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMCF-7 Cells
650 0 4 _aPeroxiredoxins
_xgenetics
700 1 _aMuhlbauer, J
700 1 _aPerlmutter, G
700 1 _aTaparra, K
700 1 _aPhelan, S A
773 0 _tInternational journal of oncology
_gvol. 45
_gno. 1
_gp. 219-26
856 4 0 _uhttps://doi.org/10.3892/ijo.2014.2398
_zAvailable from publisher's website
999 _c23788908
_d23788908